The Zacks Analyst Blog Highlights HSBC, American Express, TotalEnergies, Armanino Foods of Distinction and Precipio

For Immediate Release

Chicago, IL – September 23, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: HSBC Holdings plc (HSBC), American Express Co. AXP and TotalEnergies SE TTE, Armanino Foods of Distinction, Inc. AMNF and Precipio, Inc. PRPO.

Here are highlights from Monday’s Analyst Blog:

Top Stock Reports for HSBC, American Express and TotalEnergies

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including HSBC Holdings plc, American Express Co. and TotalEnergies SE, as well as two micro-cap stocks Armanino Foods of Distinction, Inc. and Precipio, Inc.. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.

These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today's research reports here >>>

Ahead of Wall Street

The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.

You can read today's AWS here >>> Fed Speeches Today, PCE Report End-of-Week

Today's Featured Research Reports

HSBC's shares have outperformed the Zacks Banks - Foreign industry over the year-to-date period (+48.5% vs. +43.5%). The company's business simplification and restructuring initiatives are expected to fuel long-term growth. As part of its focus on optimizing returns, the company is divesting operations in underperforming regions and has exited retail banking across multiple markets.

Though these moves position it for improved operating efficiency, they are likely to temporarily weigh on revenue growth. This, along with subdued loan demand, presents a major near-term concern for HSBC.

Higher expenses tied to efforts to expand market share remain a woe and hurt profitability. Nevertheless, a robust capital position, relatively high interest rates and an expansive global footprint will continue to support financials.

(You can read the full research report on HSBC here >>>)

Shares of American Express have outperformed the Zacks Financial - Miscellaneous Services industry over the year-to-date period (+16% vs. +10.7%). The company is benefiting from sustained revenue growth driven by new product launches, strategic partnerships and a rebound in travel and entertainment spending. It expects revenues to rise by 8-10% YOY in 2025.

Strong cash generation and disciplined capital returns underscore its financial strength. It returned $2 billion in 2Q25 through dividends and buybacks. Year-to-date, its shares have outperformed the industry. AXP's focus on increasing tech-savvy customers positions it for long-term growth.

However, persistently rising expenses continue to weigh on margins. Loan loss provisions remain elevated due to macro uncertainty. Interest expenses rose 9% YoY in the first half of 2025. AmEx's limited exposure to emerging non-card payment channels may constrain future competitiveness. As such, the stock warrants a cautious stance.

(You can read the full research report on American Express here >>>)

TotalEnergies' shares have gained +13.9% over the year-to-date period against the Zacks Oil and Gas - Refining and Marketing industry's gain of +18.9%. The company is gaining from contributions coming from startups, acquired assets, well-spread LNG assets and upstream assets located in the new hydrocarbon-producing regions.

TotalEnergies benefits from its multi-energy assets spread across the globe. Its free cash flow allows it to increase shareholders' value. TotalEnergies is investing in clean power generation and lowering emissions.

TotalEnergies operates multiple assets globally, and in some regions, production might be impacted due to security concerns. It remains exposed to acquisition-related risks as these assets contribute a sizable volume to production. The natural field decline will impact production volumes and lower profits.

(You can read the full research report on TotalEnergies here >>>)

Shares of Armanino Foods of Distinction have outperformed the Zacks Food - Miscellaneous industry over the year-to-date period (+24.2% vs. -5.3%). This microcap company with a market capitalization of $296.12 million offers a compelling investment case supported by disciplined cost control, capital discipline, and robust financial strength. Management's focus on efficiency, manufacturing productivity, and sourcing optimization builds a lean model resilient to sector softness.

A recently expanded $12 million buyback program—quadrupling repurchase volume—reinforces shareholder returns, supported by $23 million in cash, zero debt, and positive cash flow. Planned $1.5 million capex in 2025 will enhance automation and scalability, aligning with growing foodservice and international demand.

Meanwhile, diversified distribution, stable broker relationships, and strong customer acquisitions mitigate concentration risk. With a strengthening brand portfolio and strategic marketing, AMNF is well-positioned to expand its leadership in high-margin categories.

(You can read the full research report on Armanino Foods of Distinction here >>>)

Precipio's shares have outperformed the Zacks Medical Info Systems industry over the year-to-date period (+207.7% vs. +29.6%). This microcap company with a market capitalization of $27.03 million has become a profitable growth engine, delivering three straight quarters above $1.3 million/month with 28% year-over-year growth and margins inching toward a 50% target by 2026.

Cash flow funds R&D and fuels the Products pipeline. Products revenues rose in second-quarter 2025, driven by HemeScreen adoption and distributor traction, with operating leverage expected as revenue scales. Company-wide gross margin rose to 43%, with a narrowing EBITDA loss and reduced cash burn.

Termination of the ATM program and warrant restructuring reflect capital discipline, but liquidity remains fragile with $1.1 million in cash and reliance on growth to offset volatility in Products revenue, distributor dependence and customer concentration. The valuation reflects both growth potential and execution risks, with upside if profitability materializes.

(You can read the full research report on Precipio here >>>)

Why Haven't You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.

Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

[email protected]                                      

https://www.zacks.com                                                   

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research